BPG is committed to discovery and dissemination of knowledge
Articles in Press
4/2/2026 9:02:56 AM | Browse: 3 | Download: 0
Publication Name World Journal of Gastroenterology
Manuscript ID 119442
Country China
Category Gastroenterology & Hepatology
Manuscript Type Retrospective Study
Article Title Fibrosis index nine superiority for cirrhosis in hypopituitarism: Clinical validation of endocrine liver triage tool
Manuscript Source Unsolicited Manuscript
All Author List Ting Li, Xi Wang, Min Nie, Qin Han, Xue-Yan Wu and Jiang-Feng Mao
Funding Agency and Grant Number
Corresponding Author Jiang-Feng Mao, MD, Professor, Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 1 Shuaifuyuan, Dongcheng District, Beijing, China, Beijing 100730, China. maojf@pumch.cn
Key Words Hypopituitarism; Liver fibrosis; Cirrhosis; Non-invasive test; Craniopharyngioma; Fibrosis-9 index; Fibrosis-4 index; Aspartate aminotransferase-to-platelet ratio index; Liver stiffness measurement; Metabolic dysfunction-associated steatotic liver disease
Core Tip Patients with hypopituitarism are at high risk for rapidly progressive metabolic liver disease, yet traditional non-invasive tests often lack accuracy in this specific endocrine-mediated context. This study provides the first clinical validation of the fibrosis-9 (FIB-9) index in hypopituitary patients. Our findings reveal that FIB-9 (area under the receiver operating characteristic curve = 0.941) significantly outperforms aspartate aminotransferase-to-platelet ratio index, fibrosis-4, and conventional serum markers in identifying cirrhosis. Using an optimal cutoff of 1.748, FIB-9 serves as a highly reliable triage tool, enabling clinicians to accurately identify high-risk patients for advanced liver assessment while sparing others from unnecessary testing.
Citation Li T, Wang X, Nie M, Han Q, Wu XY, Mao JF. Fibrosis index nine superiority for cirrhosis in hypopituitarism: Clinical validation of endocrine liver triage tool. World J Gastroenterol 2026; In press
Received
2026-01-28 06:43
Peer-Review Started
2026-01-28 06:44
First Decision by Editorial Office Director
2026-02-26 07:57
Return for Revision
2026-02-26 07:57
Revised
2026-03-19 03:13
Publication Fee Transferred
2026-03-20 02:39
Second Decision by Editor
2026-04-02 02:37
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-04-02 09:02
Articles in Press
2026-04-02 09:02
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com